Key Focus for CVS Health Investors

By Ken Smith • Sunday, December 03 17:09 • Permanent Link

Is it worth buying CVS Health stock at a price of $68.48? If this question is on your mind, make sure to check out the fundamentals of this Pharmaceutical Retail large-cap company:

CVS Health has logged a -33.0% 52 week change, compared to 14.0% for the S&P 500
CVS has an average analyst rating of buy and is -21.12% away from its mean target price of $86.82 per share
Its trailing earnings per share (EPS) is $6.53, which brings its trailing Price to Earnings (P/E) ratio to 10.5. The Consumer Staples sector's average P/E ratio is 21.21
The company's forward earnings per share (EPS) is $8.51 and its forward P/E ratio is 8.0
The company has a Price to Book (P/B) ratio of 1.19 in contrast to the Consumer Staples sector's average P/B ratio is 4.12
The company's free cash flow for the last fiscal year was $11.3 Billion and the average free cash flow growth rate is 8.8%
CVS Health's revenues have an average growth rate of 10.2% with operating expenses growing at None%. The company's current operating margins stand at 4.0%

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.